On March 23, 2026, Vor Bio, a biotechnology company listed on Nasdaq under VOR, shared that stock options to buy 215,700 shares of Vor Bio’s common stock and restricted stock units (RSUs) for 46,235 shares were granted by the Compensation Committee to 8 new employees in November 2025 and March 23, 2026. These incentives were given for employment purposes following Nasdaq Listing Rule 5635(c)(4) and under the Vor Biopharma Inc. 2023 Inducement Plan.